RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.

Although the RA-PR058 treatment partially recovered this synaptic transmission disfunction, this recovery did not reach statistical significance ( Figure 2 B, C).

also in 111,027 other papers